Identify the evidence that reveals your value
Work with industry-recognized experts who apply scientific methodologies to conduct the full scope of health economics and outcomes research for effective strategic planning. AmerisourceBergen combines rigorous, technical expertise with an understanding of local markets and multiple disease states to deliver relevant, transparent, and credible results to help inform practical strategies and tactics that communicate a robust portfolio of value-based evidence.
Comparative effectiveness research
Generate the evidence that payers demand
When the gold standard of head-to-head clinical trial data is limited or unavailable, manufacturers turn to AmerisourceBergen for evidence synthesis through systematic review and meta-analysis. Applying more than two decades of experience in conducting literature reviews, developing dossiers, and performing complex statistical analyses in numerous therapeutic areas, we provide turnkey support.
Economic modeling
Design credible, transparent, user-friendly models that payers trust
Identify patient trends, simplify complex disease states and methodologies, and communicate value via our deep knowledge of Section 114 through a wide array of visually impactful, easy-to-use tools. Using enhanced graphics, navigation, and macros, showcase multiple data endpoints including cost-effectiveness, budget impact, or burden of disease.
495+
Economic models developed
50+
Therapeutic areas of expertise
Accurately and clearly communicating complex data
From publication strategy to medical writing, we can help. Our team of highly respected and experienced medical strategists provide clinical expertise with an eye for details that matter to key decision-makers. As your strategic partner, we'll optimize your messaging for influencers and decision-makers and help you tell a compelling value story.
Formulary Dossiers
As the leader in AMCP Format formulary dossier development, we apply a keen understanding of the reimbursement and formulary decision-making process, including knowledge of key influencers, primary drivers, and dossier utilization to clearly convey your most complex data. Our team of highly respected and experienced medical strategists possess advanced clinical backgrounds, training in effective scientific communication, and strong familiarity with US-based formulary templates.
Global Value Dossiers
We possess a deep knowledge of the access and reimbursement decision-making process across major global markets and understand the critical drivers and influencers that vary from country to country. With AmerisourceBergen, you will build a global value dossier that tells your product or technology’s story in a clear and compelling way that will support local markets in preparing their own submissions.
Scientific Publications
Benefit from our 25+ year history, an unparalleled level of scientific expertise, and the ground-up creation of hundreds of evidence dossiers, economic models, peer-reviewed posters and publications for hundreds of products and technologies. With well over 50 published manuscripts in peer-reviewed journals and more than 700 poster presentations and symposia at national conferences, turn to the experts in publication planning and execution.
Since 2006, our experience speaks volumes
530+
Dossier & Formulary kits
500+
Publications
185+
Evidence synthesis projects
Evidence synthesis and meta-analyses
Understand evidence, identify gaps, and synthesize findings to demonstrate the value of your technology.
When you need to bring clarity to an unclear treatment landscape, identify gaps in evidence generation or knowledge in the public domain, or provide the rigorous evidentiary support necessary for health technology assessments or publications, rely on AmerisourceBergen. We stay current on tools and methodologies that can help you take a step further, and conduct feasibility assessments, statistical recommendations, and quantitative analyses.
Global market access strategy
Access global solutions for local launch success
Turn to us for a deeper understanding of the approval and decision-making processes related to coverage, reimbursement, and pricing in both established and emerging markets. Understand how HTA agencies make coverage decisions. From market research and HEOR strategy to medical communications and evidence generation, AmerisourceBergen helps global market access teams prepare a product value portfolio that local decision makers find most relevant.
Outcomes analyzers
Prove effectiveness and value in real-world populations
Outcomes Analyzers are tools designed to capture and analyze an array of inputs — from pharmacy, medical, and EMR claims to patient satisfaction and laboratory results. Through this platform, real-world data stories can be revealed, whether through outcomes-based contracting, adherence program evaluation, treatment patterns and guidelines compliance, healthcare resource utilization and cost evaluations, risk assessment/identification in patient populations, quality metric evaluation and improvement, pre-post interventions, and predictive modeling based on retrospective claims.
Quality improvement programs
Increase collaboration with payers and providers
In a marketplace that increasingly demands more comparative evidence of high-cost treatments, health outcomes and economic evaluations of a disease state can help differentiate products and drive market access. Our quality improvement programs range from traditional partnerships — including educational programs and interventions — to outcome performance measurement that provides value to manufacturers, payers, providers, and patients by increasing access to care.
Training and learning solutions
HEOR Fundamental Education Series
Ensuring more members of an organization, including those outside of the Health Economics and Outcomes role, understand the quintessential part health economics and outcomes research (HEOR) plays is also proving to be of value. This is why our Learning Solutions has created 5 unique primers on HEOR.